BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li SL, Wang PY, Jia YP, Zhang ZX, He HY, Chen PY, Liu X, Liu B, Lu L, Fu WH. BIRC3 induces the phosphoinositide 3-kinase-Akt pathway activation to promote trastuzumab resistance in human epidermal growth factor receptor 2-positive gastric cancer. World J Gastrointest Oncol 2024; 16(11): 4436-4455 [PMID: 39554734 DOI: 10.4251/wjgo.v16.i11.4436]
URL: https://www.wjgnet.com/1007-9327/full/v16/i11/4436.htm
Number Citing Articles
1
Huan Zhao, Huihui Hu, Zhifei Li, Mengen Xu, Peipei miao, Beibei Chen, Xiaobing Chen. The mechanism of ncRNA in trastuzumab resistance in HER2-positive tumorsMedical Oncology 2025; 42(9) doi: 10.1007/s12032-025-02976-y
2
Hui Nian, Yu Bai, Hong-Yang Wang, Hua Yu, Zhi-Long Zhang, Ru-Hong Shi, Shu Zhang, Yi-Bin Wu, De-Hua Zhou, Qian-Cheng Du. Targeting the Osteopontin-regulated PI3K/AKT signaling pathway: A molecular approach to overcome drug resistance and metastasis in gastrointestinal tumorsWorld Journal of Gastrointestinal Oncology 2025; 17(11): 109923 doi: 10.4251/wjgo.v17.i11.109923
3
Kunjie Wang, Lin An, Aimin Zang, Yue Huo. Chidamide impedes glycolysis but increases ferroptosis and cisplatin sensitivity of lung cancer cells through downregulating USP35BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-14925-z